OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab
Gaia Meoni, Veronica Ghini, Laura Maggi, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 2, pp. e1009243-e1009243
Open Access | Times Cited: 86

Showing 26-50 of 86 citing articles:

Serum NMR Profiling Reveals Differential Alterations in the Lipoproteome Induced by Pfizer-BioNTech Vaccine in COVID-19 Recovered Subjects and Naïve Subjects
Veronica Ghini, Laura Maggi, Alessio Mazzoni, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 17

Metabolic and Immune Markers for Precise Monitoring of COVID-19 Severity and Treatment
André F. Rendeiro, Charles Kyriakos Vorkas, Jan Krumsiek, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 16

Cancer and COVID-19: unravelling the immunological interplay with a review of promising therapies against severe SARS-CoV-2 for cancer patients
Yan Leyfman, Nancy Emmanuel, Gayathri P. Menon, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 9

A platelet lipidomics signature in patients with COVID-19
Laura Goracci, Eleonora Petito, Alessandra Di Veroli, et al.
Platelets (2023) Vol. 34, Iss. 1
Open Access | Times Cited: 9

Stratification of hypertension and SARS-CoV-2 infection by quantitative NMR spectroscopy of human blood serum
Jasmin Kazenwadel, Georgy Berezhnoy, Claire Cannet, et al.
Communications Medicine (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 9

The Ability to Normalise Energy Metabolism in Advanced COVID-19 Disease Seems to Be One of the Key Factors Determining the Disease Progression—A Metabolomic NMR Study on Blood Plasma
Eva Baranovičová, Anna Bobčáková, Róbert Vyšehradský, et al.
Applied Sciences (2021) Vol. 11, Iss. 9, pp. 4231-4231
Open Access | Times Cited: 23

Breast Milk and COVID-19: From Conventional Data to “Omics” Technologies to Investigate Changes Occurring in SARS-CoV-2 Positive Mothers
Flaminia Bardanzellu, Melania Puddu, Vassilios Fanos
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 11, pp. 5668-5668
Open Access | Times Cited: 21

Metabolic Signatures of Type 2 Diabetes Mellitus and Hypertension in COVID-19 Patients With Different Disease Severity
Mohamed A. Elrayess, Farhan Cyprian, Abdallah M. Abdallah, et al.
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 15

Inflammatory Bowel Disease and COVID-19: How Microbiomics and Metabolomics Depict Two Sides of the Same Coin
Gian Mario Cortes, Maria Antonietta Marcialis, Flaminia Bardanzellu, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 14

Integrative metabolomic and proteomic signatures define clinical outcomes in severe COVID-19
Mustafa Büyüközkan, Sergio Alvarez-Mulett, Alexandra C. Racanelli, et al.
iScience (2022) Vol. 25, Iss. 7, pp. 104612-104612
Open Access | Times Cited: 14

New Insights into the Identification of Metabolites and Cytokines Predictive of Outcome for Patients with Severe SARS-CoV-2 Infection Showed Similarity with Cancer
Susan Costantini, Gabriele Madonna, Elena Di Gennaro, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4922-4922
Open Access | Times Cited: 7

Serum nuclear magnetic resonance metabolomics analysis of human metastatic colorectal cancer: Biomarkers and pathway analysis
Anne Tristan, E. González, Ana del Mar Salmerón, et al.
NMR in Biomedicine (2023) Vol. 36, Iss. 9
Open Access | Times Cited: 7

COVID-19: A complex disease with a unique metabolic signature
Veronica Ghini, Walter Vieri, Tommaso Celli, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 11, pp. e1011787-e1011787
Open Access | Times Cited: 7

Metabolomic profiling of COVID-19 using serum and urine samples in intensive care and medical ward cohorts
Anne Tristan, Cristina Jiménez‐Luna, Ana Cristina Abreu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2

Enzymes in the time of COVID‐19: An overview about the effects in the human body, enzyme market, and perspectives for new drugs
Luana Xavier Soares Gomes Moura Fé, Eliane Pereira Cipolatti, Martina C. C. Pinto, et al.
Medicinal Research Reviews (2022) Vol. 42, Iss. 6, pp. 2126-2167
Open Access | Times Cited: 10

Phenylalanine metabolism and tetrahydrobiopterin bio-availability in COVID-19 and HIV
Shayne Mason, Mari van Reenen, Theresa M. Rossouw, et al.
Heliyon (2023) Vol. 9, Iss. 4, pp. e15010-e15010
Open Access | Times Cited: 6

Skeletal Muscle and COVID-19: The Potential Involvement of Bioactive Sphingolipids
Elisabetta Meacci, Federica Pierucci, Mercedes Garcia‐Gil
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1068-1068
Open Access | Times Cited: 9

An NMR-Based Model to Investigate the Metabolic Phenoreversion of COVID-19 Patients throughout a Longitudinal Study
Rubén Gil‐Redondo, Ricardo Conde, Maider Bizkarguenaga, et al.
Metabolites (2022) Vol. 12, Iss. 12, pp. 1206-1206
Open Access | Times Cited: 9

Characterization of the Microbiome and Host’s Metabolites of the Lower Respiratory Tract During Acute Community-Acquired Pneumonia Identifies Potential Novel Markers
Qiang Xiao, Shukun Tan, Changzhi Liu, et al.
Infection and Drug Resistance (2023) Vol. Volume 16, pp. 581-594
Open Access | Times Cited: 5

Targeted plasma metabolomics combined with machine learning for the diagnosis of severe acute respiratory syndrome virus type 2
Anthony Le, Manhong Wu, Afraz A. Khan, et al.
Frontiers in Microbiology (2023) Vol. 13
Open Access | Times Cited: 5

Transcriptomic and proteomic assessment of tocilizumab response in a randomized controlled trial of patients hospitalized with COVID-19
Haridha Shivram, Jason A. Hackney, Carrie M. Rosenberger, et al.
iScience (2023) Vol. 26, Iss. 9, pp. 107597-107597
Open Access | Times Cited: 5

The biomarkers’ landscape of post-COVID-19 patients can suggest selective clinical interventions
Debora Paris, Letizia Palomba, Maria Cristina Albertini, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5

Scroll to top